DoggieDay Pet Service

Lou Whitney — CEO

Lou is the consummate entrepreneur -- this represents his seventh business venture. Previous businesses included a restaurant/catering company, a gift store, a publishing company, a mergers and acquisitions firm, and furniture and general contracting business. Prior to his own ventures, Lou held a number of positions, including VP at a national insurance provider, registrar of a technology college, materials and production coordinator for a computer manufacturer and a district manager of a fast food chain. To say he has a lot of experience to draw from to make DoggieDay a success is an understatement.

Lou served in the United States Air Force as a linguist/analyst stationed at the National Security Agency. He holds a B.A. in linguistics from the University of Maryland and an M.B.A. from Anna Maria College in Paxton MA.

Rob Galeski — President

Rob has been in charge of day to day operations for DoggieDay since its inception. He has – nearly single-handedly -- grown the business from a handful of clients in the fall of 1999 to over 500 registered clients today. In addition to DoggieDay, Rob has held a variety of positions that form his deep business knowledge. He has been a space planner, a general manager of a well known fast food franchise, and held other customer service positions within the food industry.

Rob is a graduate of Wentworth Institute of Technology and has a degree in Architectural Design.

Michael Donovan, Ph.D. M.D. — COO

Michael is the operational and development guru behind DoggieDay, and the principle investor. Although Michael maintains a professional life separate from DoggieDay, he has significant input in the area of operations and procedures.

Michael is a Board certified Pediatric Pathologist and runs a separate DoggieDay subsidiary, PathoCon, Inc. He graduated from Rutgers University with a BS in zoology, a Master's in Endocrinology, and a PhD in Cell Biology. After completing two years of post-doctoral studies at Harvard in Developmental Biology, Michael attended the University of Medicine and Dentistry of New Jersey where he received his Doctor of Medicine. He completed a residency in Anatomic and Clinical Pathology at New York Hospital/Cornell, and a fellowship in Pediatric Pathology at Children's Hospital in Boston where he also served as a staff pathologist.

He began his biotech industry experience at Millennium Pharmaceuticals where he ran the Molecular Pathology group and achieved the position of Senior Director. From there, Michael became the Senior Vice President of Oncology/Pathology at Incyte Genomics and left there in November of 2002. Today, through his work with Pathocon, Michael consults with various biotech firms in the area of predictive medicine.